Ulixertinib. Extracellular signal-regulated kinase 1/2 (ERK1/2) inhibitor, Treatment of cancers with RAS-ERK aberrant activation
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
Drugs of the future - 46(2021), 11, Seite 891 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ji, N. [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Umfang: |
1 Online-Ressource |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
KFL010940871 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL010940871 | ||
| 003 | DE-627 | ||
| 005 | 20230502163720.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230327s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)KFL010940871 | ||
| 035 | |a (KFL)prod_QApH_3328879 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Ji, N. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Ulixertinib. Extracellular signal-regulated kinase 1/2 (ERK1/2) inhibitor, Treatment of cancers with RAS-ERK aberrant activation |
| 264 | 1 | |c 2021 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 700 | 1 | |a Yang, Y. |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Y. |e verfasserin |4 aut | |
| 700 | 1 | |a Shen, W-X |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Z-S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drugs of the future |d [Philadelphia, PA] : Clarivate Analytics, 1976 |g 46(2021), 11, Seite 891 |h Online-Ressource |w (DE-627)KFL000006106 |w (DE-600)2115886-1 |w (DE-576)481527230 |x 2013-0368 |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2021 |g number:11 |g pages:891 |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/thomson-reuters-ejournals-pharmazie/integrity.clarivate.com/integrity/xmlxsl/pk_ref_list.showUniqueReferenceList?p_id=3328879 |m X:KFL |x Verlag |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-TRE | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 935 | |i IMPORT_0628_prod_QApH_02 | ||
| 951 | |a AR | ||
| 952 | |d 46 |j 2021 |e 11 |h 891 | ||